1. Home
  2. AMPH vs VSAT Comparison

AMPH vs VSAT Comparison

Compare AMPH & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • VSAT
  • Stock Information
  • Founded
  • AMPH 1996
  • VSAT 1986
  • Country
  • AMPH United States
  • VSAT United States
  • Employees
  • AMPH N/A
  • VSAT N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • AMPH Health Care
  • VSAT Technology
  • Exchange
  • AMPH Nasdaq
  • VSAT Nasdaq
  • Market Cap
  • AMPH 1.2B
  • VSAT 1.1B
  • IPO Year
  • AMPH 2014
  • VSAT 1996
  • Fundamental
  • Price
  • AMPH $23.85
  • VSAT $8.62
  • Analyst Decision
  • AMPH Hold
  • VSAT Buy
  • Analyst Count
  • AMPH 3
  • VSAT 7
  • Target Price
  • AMPH $43.50
  • VSAT $17.14
  • AVG Volume (30 Days)
  • AMPH 670.7K
  • VSAT 2.5M
  • Earning Date
  • AMPH 05-07-2025
  • VSAT 05-20-2025
  • Dividend Yield
  • AMPH N/A
  • VSAT N/A
  • EPS Growth
  • AMPH 17.69
  • VSAT N/A
  • EPS
  • AMPH 3.06
  • VSAT N/A
  • Revenue
  • AMPH $731,967,000.00
  • VSAT $4,522,502,000.00
  • Revenue This Year
  • AMPH $2.15
  • VSAT $7.52
  • Revenue Next Year
  • AMPH $6.64
  • VSAT $2.15
  • P/E Ratio
  • AMPH $7.68
  • VSAT N/A
  • Revenue Growth
  • AMPH 13.59
  • VSAT 19.02
  • 52 Week Low
  • AMPH $22.64
  • VSAT $6.69
  • 52 Week High
  • AMPH $53.96
  • VSAT $26.70
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 36.03
  • VSAT 46.26
  • Support Level
  • AMPH $22.84
  • VSAT $7.95
  • Resistance Level
  • AMPH $24.69
  • VSAT $8.94
  • Average True Range (ATR)
  • AMPH 1.17
  • VSAT 0.74
  • MACD
  • AMPH 0.02
  • VSAT -0.02
  • Stochastic Oscillator
  • AMPH 22.26
  • VSAT 57.21

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.

Share on Social Networks: